54 related articles for article (PubMed ID: 11482576)
21. [Comparison of breast cancers diagnosed in and outside of the large scale mammography program of the Ariana area of Tunisia].
Zeghal D; Mahjoub S; Zakraoui MA; Zouari F
Tunis Med; 2009 Jul; 87(7):450-3. PubMed ID: 20063678
[TBL] [Abstract][Full Text] [Related]
22. Large-core needle biopsy of nonpalpable breast lesions.
Meyer JE; Smith DN; Lester SC; Kaelin C; DiPiro PJ; Denison CM; Christian RL; Harvey SC; Selland DL; Durfee SM
JAMA; 1999 May; 281(17):1638-41. PubMed ID: 10235159
[TBL] [Abstract][Full Text] [Related]
23. National program of breast cancer early detection in Brod-Posavina County (East Croatia).
Jurišić I; Kolovrat A; Mitrečić D; Cvitković A
Coll Antropol; 2014 Sep; 38(3):961-7. PubMed ID: 25420380
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the effects of mammography screening program on cancer progression and implemented treatment in patients with breast cancer.
Nowikiewicz T; Zegarski W; Piątkowska M; Klag M
Pol Przegl Chir; 2013 Apr; 85(4):204-9. PubMed ID: 23640928
[TBL] [Abstract][Full Text] [Related]
25. Nova Scotia Breast Screening Program experience: use of needle core biopsy in the diagnosis of screening-detected abnormalities.
Caines JS; Chantziantoniou K; Wright BA; Konok GP; Iles SE; Bodurtha A; Zayid I; Daniels C
Radiology; 1996 Jan; 198(1):125-30. PubMed ID: 8539363
[TBL] [Abstract][Full Text] [Related]
26. Large-core needle biopsy of nonpalpable breast cancers. The impact on subsequent surgical excisions.
Smith DN; Christian R; Meyer JE
Arch Surg; 1997 Mar; 132(3):256-9; discussion 260. PubMed ID: 9125023
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of frozen section diagnoses of breast lesions after introduction of a national programme in mammographic screening.
Scheiden R; Sand J; Tanous AM; Knolle U; Capesius C; Wagnon MC; Faverly D
Histopathology; 2001 Jul; 39(1):74-84. PubMed ID: 11454047
[TBL] [Abstract][Full Text] [Related]
28. Improved fine needle aspiration (FNA) cytology results with a near patient diagnosis service for breast lesions.
Dray M; Mayall F; Darlington A
Cytopathology; 2000 Feb; 11(1):32-7. PubMed ID: 10714373
[TBL] [Abstract][Full Text] [Related]
29. Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands.
van Breest Smallenburg V; Nederend J; Voogd AC; Coebergh JW; van Beek M; Jansen FH; Louwman WJ; Duijm LE
Br J Cancer; 2013 Jul; 109(1):242-8. PubMed ID: 23695018
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer screening pathology: an assessment of the practise and needs in Belgium and Luxembourg.
Faverly D; Renard F; Drijkoningen M; Scheiden R
Virchows Arch; 2000 Oct; 437(4):354-9. PubMed ID: 11097359
[TBL] [Abstract][Full Text] [Related]
31. The United Kingdom national breast screening programme: implications for pathology departments.
Elston CW
Med Lab Sci; 1989 Jul; 46(3):223-9. PubMed ID: 2691798
[TBL] [Abstract][Full Text] [Related]
32. Breast screening in Singapore: implications for pathology.
Tan PH
Ann Acad Med Singap; 2007 Oct; 36(10):827-33. PubMed ID: 17987234
[TBL] [Abstract][Full Text] [Related]
33. The impact of "Be Clear on Cancer" campaign on breast care services provided by a specialist oncoplastic unit - A retrospective case control study.
Mazari FAK; Holt S; Azmy IA
Int J Surg; 2017 Nov; 47():54-60. PubMed ID: 28951287
[TBL] [Abstract][Full Text] [Related]
34. Timeliness of Breast Diagnostic Imaging and Biopsy in Practice: 15 Years of Collecting, Comparing, and Defining Quality Breast Cancer Care.
Donovan CA; Kaufman CS; Thomas KA; Polat AK; Thomas M; Mack B; Gilbert A; Sarantou T
Ann Surg Oncol; 2023 Oct; 30(10):6070-6078. PubMed ID: 37528305
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic strategy in the management of patients with breast symptoms. A recommended design and present experience.
Blichert-Toft M; Dyreborg U; Andersen J
Acta Oncol; 1988; 27(6A):597-600. PubMed ID: 3219214
[TBL] [Abstract][Full Text] [Related]
36. [Standardization for diagnostic tumor pathology (breast cancer)].
Panel members of Standardization for diagnostic tumor pathology
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):525-8. PubMed ID: 27510776
[No Abstract] [Full Text] [Related]
37. Influence of the radiographer on the pain felt during mammography.
Van Goethem M; Mortelmans D; Bruyninckx E; Verslegers I; Biltjes I; Van Hove E; De Schepper A
Eur Radiol; 2003 Oct; 13(10):2384-9. PubMed ID: 14534806
[TBL] [Abstract][Full Text] [Related]
38. Consequences of a National Mammography Screening Program on diagnostic procedures and tumor sizes in breast cancer. A retrospective study of 1540 cases diagnosed and histologically confirmed between 1995 and 1997.
Scheiden R; Sand J; Tanous AM; Capesius C; Wagener C; Wagnon MC; Knolle U; Faverly D
Pathol Res Pract; 2001; 197(7):467-74. PubMed ID: 11482576
[TBL] [Abstract][Full Text] [Related]
39. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
40. Effect of core-needle biopsy vs fine-needle aspiration on pathologic measurement of tumor size in breast cancer.
Yang JH; Lee WS; Kim SW; Woo SU; Kim JH; Nam SJ
Arch Surg; 2005 Feb; 140(2):125-8. PubMed ID: 15723992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
